ADVANCED MASTER IN BIOTECH AND MEDTECH VENTURES

Online info session

Postgraduate course in the management of Biotech and MedTech companies for Master’s and PhD graduates, or junior professionals, co-created with leading Belgian and international life sciences partners.

Agenda

Friday, 25 November 2022
12h00 - 12h30: Presentation of the Programme.
12h30 - 13h00: Q/A live session with the Academic Team.

Access

We will send you all the practical details to connect and join our Zoom meeting.

AMBT partners without SFPI-1

Build your future. Take your career
#ToTheNextLevel

You have limited professional experience and you want to skyrocket your career? You're on the right track!

Join our webinar to learn all about the Advanced Master in Biotech and MedTech Ventures:

  • 1-year programme,
  • welcoming students with an entrepreneurial spirit and the ambition to acquire the in-depth knowledge and business acumen needed to take on a (C-level) executive role in an early-stage Biotech or MedTech company.

Presented by Academic Directors Philip Vergauwen and Marc Deschamps

BIOS

Philip Vergauwen is professor of Strategic Management Accounting & Control at the Solvay Brussels School of Economics & Management (ULB), the School of which he was also Dean from 2018-2021. Previously, he chaired the University Council of Maastricht University and was Dean at both Hasselt and Maastricht.

Marc Dechamps is a biologist with extensive experience of more than 35 years in the pharmaceutical industry. Since 2016, Marc is founder and Managing Director of XMF consulting, a company which supports Biotech & BioPharma companies with strategic advice and management leadership in the field of Biologics – ATMP, ... He serves as President of the board of CEBR, the Council of European BioRegions and of "Investsud Tech" group Investsud Belgium.

Learn from leading industry experts

The Advanced Master in Biotech & MedTech Ventures is co-developed with key academic and industry partners from the Belgian & international life sciences ecosystem. Thanks to this unique collaboration, 75% of classes are taught by industry leaders, giving you direct and exclusive access to a wealth of expertise.

With practical cases and assignments, you will learn how to face the specific managerial challenges encountered throughout the different development stages in the early lifecycle of these tech-driven companies.

Your newly acquired skills will be put to the test in a real-life, in-company capstone project. The extensive hands-on experience gained in the programme will enable you to transition seamlessly into a (C-level) executive position after graduation.

TESTIMONIALS

Our academic and industry partners tell us what excites them about the programme:

Olivier Daubry

CEO & Director of AsiaBioNext (Singapur)

"This truly unique programme covers all key competencies necessary to drive the different stages of a Biotech or MedTech venture in a successful way.

There is a great, unmet need for talented individuals combining these competencies with a passion for life sciences and therapeutic innovation."

Fiona Du Monceau

COO of Exevir Bio

"Great opportunity to learn along peers with an entrepreneurial mind-set and expand your knowledge and understanding of the different elements required to build and grow a successful company.

A great step to accelerate your career and make a difference in the thriving Benelux Biotech & MedTech ecosystem."

Alain Parthoens

Founder & Managing Partner of Newton Biocapital

"Like many other industry people supporting the programme, I am pleased with this opportunity to share my 40 years of experience and expertise in life sciences with the students.

The insider perspectives and ‘lessons learned’ we share, will help them in making the right decisions throughout their careers."

Paul Van Dun

Director Technology Transfer

"I’m impressed by both the scope and the depth of the curriculum.

What the students will learn in this intensive one-year programme would otherwise take years of on-the-job training, giving them a significant head-start in their careers.

I only wish such an Advanced Master existed when I started my career some 30 years ago."

Michel Lussier

Co-Founder & Chairman of the Board of Directors of Celyad Oncology SA (Canada)

"It is well known that Belgian Biotech, MedTech and Digital Health are flourishing. Private and public capital funding is more and more present. We unfortunately suffer cruelly
from a lack of well-trained entrepreneurs.

This is why the AMP brings a very important, modern and effective solution to strengthen our Belgian ecosystem toward a leadership position in Europe."

I3h Institute

"The I3h Institute is very pleased to contribute to this unique programme targeted towards the

next generation of healthcare professionals, building on its expertise in Interdisciplinary Healthcare Innovation training."

Olivier Daubry

CEO & Director of AsiaBioNext (Singapur)

"This truly unique programme covers all key competencies necessary to drive the different stages of a Biotech or MedTech venture in a successful way.

There is a great, unmet need for talented individuals combining these competencies with a passion for life sciences and therapeutic innovation."

Fiona Du Monceau

COO of Exevir Bio

"Great opportunity to learn along peers with an entrepreneurial mind-set and expand your knowledge and understanding of the different elements required to build and grow a successful company.

A great step to accelerate your career and make a difference in the thriving Benelux Biotech & MedTech ecosystem."

Alain Parthoens

Founder & Managing Partner of Newton Biocapital

"Like many other industry people supporting the programme, I am pleased with this opportunity to share my 40 years of experience and expertise in life sciences with the students.

The insider perspectives and ‘lessons learned’ we share, will help them in making the right decisions throughout their careers."

Paul Van Dun

Director Technology Transfer

"I’m impressed by both the scope and the depth of the curriculum.

What the students will learn in this intensive one-year programme would otherwise take years of on-the-job training, giving them a significant head-start in their careers.

I only wish such an Advanced Master existed when I started my career some 30 years ago."

Michel Lussier

Co-Founder & Chairman of the Board of Directors of Celyad Oncology SA (Canada)

"It is well known that Belgian Biotech, MedTech and Digital Health are flourishing. Private and public capital funding is more and more present. We unfortunately suffer cruelly
from a lack of well-trained entrepreneurs.

This is why the AMP brings a very important, modern and effective solution to strengthen our Belgian ecosystem toward a leadership position in Europe."

I3h Institute

"The I3h Institute is very pleased to contribute to this unique programme targeted towards the

next generation of healthcare professionals, building on its expertise in Interdisciplinary Healthcare Innovation training."